A Prospective, Randomized, Double Blinded, Crossover, Two-treatment, Two-sequence, Short Term Pharmacokinetic, Pharmacodynamic and Tolerability, Single Centre Study to Compare AOP200704 vs. Esmolol in Healthy Subjects.

Trial Profile

A Prospective, Randomized, Double Blinded, Crossover, Two-treatment, Two-sequence, Short Term Pharmacokinetic, Pharmacodynamic and Tolerability, Single Centre Study to Compare AOP200704 vs. Esmolol in Healthy Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jul 2012

At a glance

  • Drugs Esmolol; Landiolol
  • Indications Arrhythmias
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 11 Jul 2012 Actual end date changed from Apr 2011 to Jan 2012 as reported by ClinicalTrials.gov.
    • 10 Mar 2012 Actual end date (Apr 2011) added as reported by European Clinical Trials Database.
    • 10 Mar 2012 Actual initiation date changed from Mar 2011 to Feb 2011 as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top